🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congrats to our eContour & MIM Software Travel Award Winners for #ACRO2025!

Beta version of our app to predict the site of primary cancer in the setting of metastatic cancer (e.g., based on imaging without biopsy): primarycancerpredictor.netlify.app The accuracy is ~85%. Full manuscript coming soon.

Proud of Firas E presentation of oncotype after preop boost at Miami Breast. ⁦Bruce Haffty⁩ ⁦Rutgers Cancer Institute⁩

It was awesome to meet one of the visionaries in our field Lauren Henke, MD, MSCI for Grand Rounds at Rutgers Cancer Institute and learn about adaptive RT from the source!

A huge congrats to all the med studs that matched. To those that didn’t. Do not let that define you. It’s a short bump on a very long road. You are worth it and the system is overall pretty messed up. It’s about how you pick yourself up and move on. Let that be what defines

Isodose hypofractionation has similar outcome as conventional fractionation while higher dose hypofractionation had more GI toxicity. Is it time to switch to 60 in 20 from 70 in 28 ?

Excited to share that two of our abstracts were accepted for online publication at ASCO 2025!! Huge thanks to my amazing mentor Sean Collins Prostate SBRT @ USF Health and shoutout to the amazing students Sukhjeevan Nijhar and Srinivas Sowmiyanarayanan! ☢️ #ASCO #ProstateCancer #QOL

So excited to welcome these two incredible residents!!

Congrats to our newest Chief Residents!!

Imagine a medical TV show but its a RadOnc dept and shot like The Office

Residents: Struggling to evaluate HDR Prostate Brachytherapy plans? Read this technical report from American Brachy, pre-proof available in PRO. Thanks to Lara Hathout for her mentorship. sciencedirect.com/science/articl…

Congrats Samar!

Clear benefit of SBRT over low dose palliative RT. Shocked JCO approved of the conclusion stating only it “failed” at 1m. A small trial demonstrating 10% plus absolute CR benefits to SBRT that reach SS by 3m is impactful.

This #MondaysAtTheMorris, get a sneak peek at one of our linear accelerators! 🫣 The Jack & Sheryl Morris Cancer Center will be home to four linear accelerators and diagnostic radiology including CT, MRI, mammography and others. cinj.org/MorrisCancerCe… Rutgers Cancer Institute RWJBarnabas

We’ve hit >45,000 plays in 100+ countries with nearly 800 followers! We love you guys!! PS always open to input on how to improve the show!

This was such a great experience working with some of the leaders across the country! Thanks to Lara Hathout for her guidance in this project. S/o to Ulysses G. Gardner, MD Pretesh Surendra Prajapati, MS, PhD, DABR (he, him, his) DrKamrava Irina Vergalasova, Hong Zhang, Daniel Song

Would be great to live in precedented times...

7/ Radiation + IO? Compelling data! 🧬 Radiation modulates tumor microenvironment 🧬 May overcome immune resistance 💥 Trials are underway combining SBRT with checkpoint inhibitors (e.g., NCT05366829 Salma Jabbour)